Life Science Leader Magazine Supplements

CMO 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/792774

Contents of this Issue

Navigation

Page 60 of 81

K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 59 CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY QUALITY 2017 CMO LEADERSHIP AWARDS WINNERS Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clincial, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, capsules, cartridges, controlled substances, creams & ointments, gels, generics, injectables, liquids, lyophilized products, non-sterile, oph- thalmics, OTC, parenterals: large volume, paren- terals: small volume, powders: non-sterile, pow- ders: sterile, semisolids, solid dose, solutions & suspensions, sterile, sustained release, topicals "I am very pleased that Recipharm has once again been recognized for a CMO Leadership Award. We work extremely hard with our processes to ensure that our customers benefit from the reliability, pharmaceutical expertise, and ability to manage complexity which we offer." DRUG TYPE: Pharmaceuticals THOMAS ELDERED CEO CATEGORIES WON: Recipharm AB Stockholm, Sweden www.recipharm.com Phone: +46 8 602 52 00 Contact: Aaron Smalls Email: info@recipharm.com Key locations: Sweden, France, Italy, Spain, Germany, UK, Portugal DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre- Clincial, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development SERVICES & CAPABILITIES: cytotoxic & high potency compounds, generics, liquids, lyophilized products, parenterals: small volume, solid dose, sustained release "This is the first time ever Sai has been recognized in all six categories, which has both surprised and delighted us. Over the past 12-18 months we have spend tremendous effort in improving our busi- ness processes, and added required infrastruc- ture. Sai is all about making it better together and we believe the main reason for receiving these awards is our willingness and openness to listen to our customers always and then act on it." DRUG TYPE: Pharmaceuticals KRISHNA KANUMURI CEO CATEGORIES WON: Sai Life Sciences Hyderabad, Telangana, India www.sailife.com Phone: +91 (0)40 331 56000 Contact: Marcel Velterop Email: marcel.v@sailife.com Key locations: Hyderabad, India; Karnataka, India DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, injectables, liquids, lyophilized products, proteins "Samsung BioLogics is honored to once again be rec- ognized as winner of the CMO Leadership Awards. Meeting all core criteria — development, quality, expertise, reliability, capabilities, and compatability — we are a full service provider for mammalian bio- pharmaceutical products from clinical development to commercial manufacturing in our state-of-the-art facilities. From recent successful IPO we'll continue to provide quality-driven cGMP manufacturing for flexible and cost-effective services that ensure dedi- cated support for our clients and their patients." DRUG TYPE: Biopharmaceuticals TH KIM President & CEO CATEGORIES WON: Samsung BioLogics Songdo-dong, Yeonsu-gu, South Korea www.samsungbiologics.com Phone: +82 32 455 9334 Contact: Jungyeon Lee Email: jung-y.lee@samsung.com Key locations: Incheon, Songdo, South Korea INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, on-time, reputa- tion, right first time, state-of-the-art, strength of science INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2017